NCT07370506 2026-01-29
Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
Phase 1/2 Not yet recruiting
Clinical Trials
4 trialsNCT06815497 2026-01-28
Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer
Dartmouth-Hitchcock Medical Center
Phase 2 Recruiting
NCT06168487 2025-08-21
Telmisartan in Prostate Cancer
Dartmouth-Hitchcock Medical Center
Phase 1 Recruiting
NCT05322889 2024-08-28
PrevTel
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Phase 2 Completed